Crowdonomics
All companies
Syntensor logo

Syntensor

Operating

Syntensor Inc

Healthcare · Founded 2019

Improving the effectiveness of drug development through ai models

Valuation cap ⓘ
$20.0M
As of Oct 2024 · from Reg CF Offering (2024) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$8,040,687
Crowd $4.2M · Private $3.8M · 3 rounds since 2023

Financials

FY2022–FY2025 · from SEC filings · hover any figure for its source
$0
−$1.7M
2022
$0
−$1.8M
2023
$0
−$1.2M
2024
$0
−$1.8M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 audited*
FY2023 audited*
FY2024 unaudited
FY2025 unaudited
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
Net income
-$1,671,734
-$1,832,310
-$1,187,440
-$1,767,054
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$520,869
$31,278
$3,356,574
$1,693,803
Accounts receivable
$0
$0
$0
$0
Total assets
$604,983
$130,114
$3,606,336
$2,005,764
Short-term debt
$49,657
$202,975
$7,028
$0
Long-term debt
$7,018
$1,166,848
$5,893,927
$6,093,927
Total liabilities
$56,675
$1,369,823
$5,900,955
$6,093,927
Other
Headcount
—
4
6
5

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$20.0M
Valuation cap
Reg CF · SAFE · Aug 2024

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Fundraising history

Reg CF · SAFE · Aug 2024Closedvia Republic
Raised $4.2M / $5MInvestors 2,823Valuation cap $20M

Team

3 people
Clayton Rabideau
Chief Executive Officer
John Noonan
Director
Ripduman Sohan
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Compliant

Filed 2 of 2 annual reports (FY2024–FY2025)

2,823 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARApr 30, 20260002030174-26-000003
    EDGAR
  • Form C-ARApr 30, 20250002030174-25-000001
    EDGAR
  • Form C-UOct 8, 20240002030174-24-000002
    EDGAR
  • Form CAug 1, 20240002030174-24-000001
    EDGAR
Source: ManualCIK 0002030174

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.